CHINA PHARMA HOLDINGS, INC. Amortization
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Amortization of $851.61 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. amortization for fiscal 2025 was $851.61K, a 90.41% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. amortization for fiscal 2024 was $447.24K.
| Period end | Amortization 12 month |
|---|---|
| 2025-12-31 | $851.61K 10-K · filed 2026-04-01 |
| 2024-12-31 | $447.24K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |